Home Companies Piramal Pharma clocks 11% revenue growth in quarter ending September

Piramal Pharma clocks 11% revenue growth in quarter ending September

04:17

Company's Ebitda grows 44% year-on-year, Chairperson Nandini Piramal anticipates a stronger financial performance in H2

from Companies https://ift.tt/xYpkQyM

No comments:

Subscribe to: Post Comments ( Atom )